{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:21:58Z","timestamp":1781205718240,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejpb.2024.114603","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T17:03:01Z","timestamp":1733331781000},"page":"114603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Application of microarray patches for the transdermal administration of psychedelic drugs in micro-doses"],"prefix":"10.1016","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4300-8972","authenticated-orcid":false,"given":"Octavio E.","family":"Fandi\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.J.","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6797-6380","authenticated-orcid":false,"given":"Marco T.A.","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara A.","family":"Naser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5788-6574","authenticated-orcid":false,"given":"Yaocun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0414-8972","authenticated-orcid":false,"given":"Alejandro J.","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0766-4147","authenticated-orcid":false,"given":"Ryan F.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2024.114603_b0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/a-1310-3990","article-title":"The history of psychedelics in psychiatry","volume":"54","author":"Nichols","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ejpb.2024.114603_b0010","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320950567","article-title":"The therapeutic potential of microdosing psychedelics in depression","volume":"10","author":"Kuypers","year":"2020","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.ejpb.2024.114603_b0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neubiorev.2020.03.017","article-title":"Long-term effects of psychedelic drugs: a systematic review","volume":"113","author":"Aday","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejpb.2024.114603_b0020","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1007\/s11033-020-06009-x","article-title":"Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review","volume":"47","author":"DiVito","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejpb.2024.114603_b0025","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jad.2022.09.168","article-title":"Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis","volume":"322","author":"Ko","year":"2023","journal-title":"J Affect Disord"},{"key":"10.1016\/j.ejpb.2024.114603_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109294","article-title":"Mescaline: The forgotten psychedelic","volume":"222","author":"Vamvakopoulou","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejpb.2024.114603_b0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresbull.2016.04.016","article-title":"Neuropharmacology of N,N-dimethyltryptamine","volume":"126","author":"Carbonaro","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejpb.2024.114603_b0040","article-title":"Short-term safety and tolerability profile of 5-methoxy-N,N-dimethyltryptamine in human subjects: a systematic review of clinical trials","volume":"15","author":"Kwa\u015bny","year":"2024","journal-title":"Front Psych."},{"key":"10.1016\/j.ejpb.2024.114603_b0045","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1007\/s00213-018-5049-7","article-title":"Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting","volume":"235","author":"Prochazkova","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejpb.2024.114603_b0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/02791072.2019.1593561","article-title":"Might microdosing psychedelics be safe and beneficial? an initial exploration","volume":"51","author":"Fadiman","year":"2019","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.ejpb.2024.114603_b0055","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/0269881119857204","article-title":"Microdosing psychedelics: More questions than answers? an overview and suggestions for future research","volume":"33","author":"Kuypers","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejpb.2024.114603_b0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/02791072.2020.1718250","article-title":"Psychedelic microdosing: prevalence and subjective effects","volume":"52","author":"Cameron","year":"2020","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.ejpb.2024.114603_b0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/09540261.2018.1482261","article-title":"Therapeutic use of classic psyched.elics to treat cancer-related psychiatric distress","volume":"30","author":"Ross","year":"2018","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.ejpb.2024.114603_b0070","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00213-022-06065-0","article-title":"Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT","volume":"239","author":"Barker","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejpb.2024.114603_b0075","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s13346-021-00909-6","article-title":"Enhancement strategies for transdermal drug delivery systems: current trends and applications","volume":"12","author":"Ramadon","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2024.114603_b0080","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.3390\/pharmaceutics14061152","article-title":"Beneath the skin: a review of current trends and future prospects of transdermal drug delivery systems","volume":"14","author":"Alkilani","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114603_b0085","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4155\/tde-2017-0028","article-title":"How Can Microneedles Overcome Challenges Facing Transdermal Drug delivery?","volume":"8","author":"Donnelly","year":"2017","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejpb.2024.114603_b0090","doi-asserted-by":"crossref","first-page":"31300","DOI":"10.1021\/acsami.3c05553","article-title":"Polymeric microarray patches for enhanced transdermal delivery of the poorly soluble drug olanzapine","volume":"15","author":"McKenna","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejpb.2024.114603_b0095","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202005792","article-title":"Microarray patches: poking a hole in the challenges faced when delivering poorly soluble drugs","volume":"31","author":"Paredes","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ejpb.2024.114603_b0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2023.05.038","article-title":"Microarray patches for managing infections at a global scale","volume":"359","author":"Anjani","year":"2023","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejpb.2024.114603_b0105","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jconrel.2023.02.031","article-title":"Hydrogel-forming microarray patch mediated transdermal delivery of tetracycline hydrochloride","volume":"356","author":"Zhao","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114603_b0110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2020.03.026","article-title":"Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery","volume":"322","author":"Courtenay","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114603_b0115","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s11095-014-1301-y","article-title":"Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: a pilot study centred on pharmacist intervention and a patient information leaflet","volume":"31","author":"Donnelly","year":"2014","journal-title":"Pharm. Re."},{"key":"10.1016\/j.ejpb.2024.114603_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119580","article-title":"Development and characterisation of novel poly (vinyl alcohol)\/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate","volume":"586","author":"Tekko","year":"2020","journal-title":"Int. J .Pharm."},{"key":"10.1016\/j.ejpb.2024.114603_b0125","doi-asserted-by":"crossref","unstructured":"R.F. Donnelly, M.T.C. McCrudden, A. Zaid Alkilani, E. Larra\u00f1eta, E. McAlister, A.J. Courtenay, M.-C. Kearney, T.R.R. Singh, H.O. McCarthy, V.L. Kett, E. Caffarel-Salvador, S. Al-Zahrani, A.D. Woolfson, Hydrogel-Forming microneedles prepared from \u201csuper swelling\u201d polymers combined with lyophilised wafers for transdermal drug delivery, PLoS One 9 (2014) e111547. doi: 10.1371\/journal.pone.0111547.","DOI":"10.1371\/journal.pone.0111547"},{"key":"10.1016\/j.ejpb.2024.114603_b0130","unstructured":"H. Omidian, S.-A. Hasherni, F. Askari, S. Nafisi, Swelling and crosslink density measurements for hydrogels, 1994. https:\/\/www.researchgate.net\/publication\/242140037."},{"key":"10.1016\/j.ejpb.2024.114603_b0135","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.eurpolymj.2004.11.034","article-title":"Swelling behaviors, tensile properties and thermodynamic studies of water sorption of 2-hydroxyethyl methacrylate\/epoxy methacrylate copolymeric hydrogels","volume":"41","author":"Wang","year":"2005","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.ejpb.2024.114603_b0140","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.eurpolymj.2008.12.019","article-title":"Investigation of swelling and network parameters of poly(ethylene glycol)-crosslinked poly(methyl vinyl ether-co-maleic acid) hydrogels","volume":"45","author":"Raj Singh","year":"2009","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.ejpb.2024.114603_b0145","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/pharmaceutics7030305","article-title":"Effect of crosslinking agent concentration on the properties of unmedicated hydrogels","volume":"7","author":"Wong","year":"2015","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114603_b0150","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2014.05.042","article-title":"A proposed model membrane and test method for microneedle insertion studies","volume":"472","author":"Larra\u00f1eta","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114603_b0155","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejpb.2020.12.003","article-title":"Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs","volume":"158","author":"Anjani","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2024.114603_b0160","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jconrel.2023.03.003","article-title":"Hydrogel-forming microarray patches with solid dispersion reservoirs for transdermal long-acting microdepot delivery of a hydrophobic drug","volume":"356","author":"Naser","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114603_b0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2019.10.004","article-title":"Solid lipid nanoparticle-based dissolving microneedles: a promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis","volume":"316","author":"Permana","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114603_b0170","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jconrel.2017.07.032","article-title":"Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis","volume":"265","author":"Gonz\u00e1lez-V\u00e1zquez","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114603_b0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jconrel.2018.11.002","article-title":"Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension","volume":"292","author":"Mc Crudden","year":"2018","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejpb.2024.114603_b0180","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.microc.2013.03.009","article-title":"Investigations into the polymorphic properties of N,N-dimethyltryptamine by X-ray diffraction and differential scanning calorimetry","volume":"110","author":"Gaujac","year":"2013","journal-title":"Microchem. J."},{"key":"10.1016\/j.ejpb.2024.114603_b0185","doi-asserted-by":"crossref","first-page":"32067","DOI":"10.1021\/acsomega.0c05099","article-title":"Synthesis and characterization of 5-MeO-DMT succinate for clinical use","volume":"5","author":"Sherwood","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejpb.2024.114603_b0190","first-page":"585","article-title":"Mechanochemical synthesis of a novel eutectic of the antimicrobial nitazoxanide with improved dissolution performance","volume":"27","author":"Fandi\u00f1o","year":"2021","journal-title":"Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114603_b0195","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1021\/acs.cgd.9b01435","article-title":"Novel cocrystals and eutectics of the antiprotozoal tinidazole: mechanochemical synthesis, cocrystallization, and characterization","volume":"20","author":"Fandi\u00f1o","year":"2020","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejpb.2024.114603_b0200","unstructured":"P. Costa, J. Manuel, S. Lob\u00f4\u0301\u0301, Modeling and comparison of dissolution profiles, 2001. www.elsevier.nl\/locate\/ejps."},{"key":"10.1016\/j.ejpb.2024.114603_b0205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0378-5173(83)90064-9","article-title":"Mechanisms of solute release from porous hydrophilic polymers","volume":"15","author":"Korsmeyer","year":"1983","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114603_b0210","unstructured":"DrugBank, 5-methoxy-N,N-dimethyltryptamine, Compound Summary (n.d.). https:\/\/go.drugbank.com\/drugs\/DB14010 (accessed November 14, 2024)."},{"key":"10.1016\/j.ejpb.2024.114603_b0215","unstructured":"PubChem, Dimethyltryptamine, Compound Summary (n.d.). https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Dimethyltryptamine (accessed November 14, 2024)."},{"key":"10.1016\/j.ejpb.2024.114603_b0220","unstructured":"PubChem, Mescaline, Compounds Summary (n.d.). https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Mescaline (accessed November 14, 2024)."},{"key":"10.1016\/j.ejpb.2024.114603_b0225","article-title":"Effect of glycols permeation enhancer on the release and permeation of meloxicam-natural rubber film through pig skin","volume":"66","author":"Suksaeree","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2024.114603_b0230","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-019-1481-1","article-title":"Effects of temperature and humidity on the skin permeation of hydrophilic and hydrophobic drugs","volume":"20","author":"Iikura","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2024.114603_b0235","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/0269881118769063","article-title":"The epidemiology of 5-methoxy- N, N -dimethyltryptamine (5-MeO-DMT) use: benefits, consequences, patterns of use, subjective effects, and reasons for consumption","volume":"32","author":"Davis","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejpb.2024.114603_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.1049643","article-title":"Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: an initial exploratory analysis of the phenomenon\u2019s predictors and its emotional valence","volume":"13","author":"Ortiz Bernal","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.ejpb.2024.114603_b0245","unstructured":"H.-W. Shen, X.-L. Jiang, J.C. Winter, A.-M. Yu, Psychedelic 5-Methoxy-N,N-dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions, n.d."},{"key":"10.1016\/j.ejpb.2024.114603_b0250","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/0006-2952(87)90118-3","article-title":"In vivo metabolism of 5-methoxy-N, N-dimethyltryptamine and N,N-dimethyltryptamine in the rat","volume":"36","author":"Sitaram","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejpb.2024.114603_b0255","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00213-007-0926-5","article-title":"Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose","volume":"196","author":"P\u00e1len\u00ed\u010dek","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejpb.2024.114603_b0260","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1021\/acsmedchemlett.3c00077","article-title":"Orally active forms of DMT, 5-MeO-DMT, and long-acting MDMA for the treatment of neuropsychiatric disorders","volume":"14","author":"Kargbo","year":"2023","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.ejpb.2024.114603_b0265","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF02157378","article-title":"Dimethyltryptamin: its metabolism in man; the relation of its psychotic effect to the serotonin metabolism","volume":"12","author":"Sz\u00e1ra","year":"1956","journal-title":"Experientia"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124004296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124004296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T19:43:05Z","timestamp":1738438985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641124004296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":53,"alternative-id":["S0939641124004296"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114603","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of microarray patches for the transdermal administration of psychedelic drugs in micro-doses","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114603"}}